Investing.com - Financial Markets Worldwide

AstraZeneca director acquires ADSs through dividend reinvestment

Published 25/09/2025, 18:34
AstraZeneca director acquires ADSs through dividend reinvestment
AZN
1.03%

AstraZeneca PLC (NASDAQ:AZN) reported Thursday that Non-Executive Director Karen Knudsen acquired 9 American Depositary Shares (ADSs) of the company on September 9, 2025. The transaction was conducted through the reinvestment of the company’s first interim dividend for the year ending December 31, 2025, which was paid on September 8, 2025.

According to the company’s statement, two ADSs are equivalent to one ordinary share of AstraZeneca with a nominal value of $0.25 each. The shares were acquired at a price of $81.0499 per ADS on the NASDAQ exchange.

The company disclosed that it was notified of the transaction on Thursday. The notification was made in accordance with requirements under the EU Market Abuse Regulation, as retained in UK law.

The information in this article is based on a press release statement and a filing with the U.S. Securities and Exchange Commission.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.